Chargement en cours...
Histone Methyltransferase EZH2: A therapeutic target for ovarian cancer
Ovarian cancer is the fifth leading cause of cancer-related deaths in females in the United States. It is anticipated that there will be about 22,440 new cases and 14,080 deaths due to ovarian cancer in 2017. Most patients present with advanced stage disease, revealing the urgent need for new therap...
Enregistré dans:
| Publié dans: | Mol Cancer Ther |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5939583/ https://ncbi.nlm.nih.gov/pubmed/29726819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0437 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|